Skip to content

    Deepak Nitrite

    DEEPAKNTRGood
    Chemicals·29 May 2025
    Management Summary

    Deepak Nitrite delivered a resilient performance in FY25 despite significant headwinds from Chinese dumping and a global slowdown in agrochemicals. Q4 marked a sharp recovery with record production volumes and sequential margin expansion driven by debottlenecking and cost optimization. The company is pivoting towards high-value downstream derivatives with a massive ₹8,500 crore investment in Polycarbonate resins and backward integration into Nitric Acid.

    Highlights

    8
    • Consolidated Revenue for FY25 reached ₹8,366 crores, representing an 8% YoY growth.

    • Q4 FY25 Revenue stood at ₹2,202 crores, up 14% sequentially and 3% YoY.

    • EBITDA for Q4 FY25 rose 79% QoQ to ₹339 crores, with margins improving to approximately 15.4%.

    • PAT for Q4 FY25 more than doubled sequentially to ₹202 crores (up 106% QoQ).

    • Phenolics segment reported record FY25 revenue of ₹5,805 crores, up 16% YoY.

    • Board maintained a dividend of ₹7.5 per share (375% of face value).

    • Total investment in the Polycarbonate (PC) resins project increased to ₹8,500 crores.

    • Advanced Intermediates segment saw a 19% sequential revenue recovery in Q4 to ₹654 crores.

    Concerns

    1
    • Chinese Overcapacity and Dumping

    What Changed1

    vs Q1 FY26

    Risks discussed4 → 3 (-1)

    Key financials

    Single quarter

    05 metrics
    1. 01Revenue₹8,366 Cr+8%YoY
    2. 02EBITDA₹1,176 Cr-1.9%YoY
    3. 03EBITDA Margin14%
    4. 04PAT₹697 Cr+106%QoQ
    5. 05Net Worth₹5,425 Cr

    Segment breakdown

    • Phenolics₹5,805 Cr69.7%
    • Advanced Intermediates₹2,527 Cr30.3%
    Donut· Share of Revenue

    Guidance & targets

    5
    CategoryTargetPriority
    Capex
    Cash Capex
    ₹1,200-1,500 crores
    High
    Capacity
    Polycarbonate Resins Project Investment
    ₹8,500 crores
    High
    Capacity
    Nitric Acid Unit Commissioning
    Q1/Q2 FY26
    High
    Capacity
    MIBK and MIBC Project Commissioning
    H2 FY26
    Medium
    Other
    Renewable Energy Mix
    60-70%
    High

    Risks & concerns

    6
    RiskSeverity

    Chinese Overcapacity and Dumping

    Intense price competition from Chinese producers aggressively placing supplies exerted margin pressure.Both acknowledged

    high

    Agrochemical Demand Softness

    Management expects subdued agrochemical demand to persist for the next couple of quarters.Management acknowledged

    medium

    Geopolitical Uncertainties

    Geopolitical tensions and tariff ambiguity have led to a 'wait-and-watch' mode in global markets.Management acknowledged

    medium

    Areas of Evasion(3)

    • Specific capacity numbers for the phenol plant after debottlenecking
    • Anchor customer percentage for the Polycarbonate project
    • Specific revenue from the new compounding facility

    Q&A highlights

    3

    “To be honest, we are actually quite well aligned with a lot of other players who say that the down cycle of agrochemicals is petering over to the end... we're confident about coming back to a normalized number, which is higher than the Q3, obviously, higher than the Q4.”

    Confirms management's view that the worst of the Chinese dumping and agrochemical downcycle is likely over.

    asked by Sanjesh Jain, ICICI Securities

    2 min read6 chapters

    Detailed Narrative

    01

    Q4 Recovery Amidst Sector Headwinds

    Deepak Nitrite reported a strong sequential recovery in Q4 FY25, with consolidated revenue rising 14% to ₹2,202 crores. This was driven by record production volumes across several key products, helping offset lower realizations caused by Chinese dumping. EBITDA margins expanded significantly to 15.4% in Q4, aided by cost optimization and the recognition of ₹161 crores in accumulated government incentives.

    02

    Phenolics Segment: Volume-Led Resilience

    The Phenolics segment remains the company's growth engine, contributing ₹5,805 crores in FY25 revenue, a 16% YoY increase. Despite a temporary rise in imports and pricing pressure in Q3, the segment achieved higher volumes across all product lines in Q4. Management is now focusing on downstream derivatives like MIBK and MIBC, set to commission in H2 FY26, to further enhance value addition.

    03

    Advanced Intermediates: Navigating the Agrochemical Slump

    The Advanced Intermediates (AI) segment faced a challenging year with a 7% YoY revenue decline to ₹2,527 crores, primarily due to the global agrochemical slowdown. However, Q4 saw a 19% sequential revenue uptick to ₹654 crores as demand for dyes and pigments began to stabilize. Management expects agrochemical demand to remain subdued for another two quarters but is optimistic about a 'normalized' margin recovery on an annual basis.

    04

    Strategic Backward Integration (Nitric Acid)

    A critical component of Deepak's margin expansion strategy is the upcoming commissioning of its Nitric Acid unit in Q1/Q2 FY26. This upstream integration is expected to reduce costs, improve reliability, and enhance sustainability scores. The company has already invested in ammonia storage and pipeline infrastructure to ensure a strategically derisked sourcing strategy for this key feedstock.

    05

    The ₹8,500 Crore Polycarbonate Bet

    The Board has significantly increased the scope of its Polycarbonate (PC) resins project, with total investment now pegged at ₹8,500 crores. This includes ₹3,500 crores for new capacities in phenol, acetone, and IPA. Once commissioned by December 2027, Deepak will become one of the world's largest single-location producers of phenol and acetone, with over half the capacity converted into high-value derivatives like bisphenol and PC resins.

    06

    Energy Transition and ESG Goals

    Deepak Nitrite is executing a major transformation in its energy mix, targeting 60% to 70% renewable energy consumption in Gujarat and Maharashtra by the end of next year. This shift is projected to result in a 60% reduction in carbon emissions. The company is also investing over ₹100 crores in a state-of-the-art R&D center in Savli, Vadodara, to drive future innovation in specialty chemicals.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.